[HTML][HTML] Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy
VA Papadimitrakopoulou, JJ Lee… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Journal of Clinical Oncology, 2009•ncbi.nlm.nih.gov
Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without
Beta-Carotene in Oral Premalignancy - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2645856 Other Formats PDF (167K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Beta-Carotene in Oral Premalignancy - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC2645856 Other Formats PDF (167K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
To investigate whether retinyl palmitate (RP) alone or plus beta-carotene (BC) would be as effective and less toxic than low-dose 13-cis retinoic acid (13cRA) in treating oral premalignant lesions (OPLs) and reducing the risk of oral cancer.
ncbi.nlm.nih.gov
